The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2015

Filed:

Aug. 25, 2011
Applicants:

Shriprakash Dhar Dwivedi, Gujarat, IN;

Ashok Prasad, Gujarat, IN;

Kuldeep Natwarlal Jain, Gujarat, IN;

Inventors:

Shriprakash Dhar Dwivedi, Gujarat, IN;

Ashok Prasad, Gujarat, IN;

Kuldeep Natwarlal Jain, Gujarat, IN;

Assignee:

Cadila Healthcare Limited, Ahmedabad, Gujarat, IN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 69/76 (2006.01); C07C 219/28 (2006.01); C07C 41/26 (2006.01); C07C 51/43 (2006.01); C07C 59/56 (2006.01); C07C 67/03 (2006.01); C07C 213/10 (2006.01); C07C 217/62 (2006.01); C07C 309/66 (2006.01); C07C 213/00 (2006.01); C07C 213/06 (2006.01); C07C 213/08 (2006.01); C07C 303/28 (2006.01); C07C 309/67 (2006.01);
U.S. Cl.
CPC ...
C07C 219/28 (2013.01); C07C 41/26 (2013.01); C07C 51/43 (2013.01); C07C 59/56 (2013.01); C07C 67/03 (2013.01); C07C 213/10 (2013.01); C07C 217/62 (2013.01); C07C 309/66 (2013.01); C07C 213/00 (2013.01); C07C 213/06 (2013.01); C07C 213/08 (2013.01); C07C 303/28 (2013.01); C07C 309/67 (2013.01); C07B 2200/07 (2013.01); C07B 2200/13 (2013.01);
Abstract

The invention relates to improved process for the preparation of fesoterodine and its pharmaceutically acceptable salt, specifically fesoterodine fumarate of formula (1). The invention relates to solid state forms of a novel salt of fesoterodine and process for the preparation thereof. The invention also relates to highly pure fesoterodine fumarate substantially free of impurity X at RRT 1.37. The invention also provides solid particles of pure fesoterodine fumarate wherein 90 volume-percent of the particles (D90) have a size of higher than 200 microns.


Find Patent Forward Citations

Loading…